Could Evolence Be The Fountain Of Youth?

The protein which is largely responsible for the elasticity of your skin, collagen is depleted as we age; and this leads to the wrinkling which is common as we get older. This collagen depletion and wrinkling can be sped up by various factors such as smoking, exposure to the sun and hereditary factors. By using a collagen based dermal filler; you can return your skin to a vibrant, youthful look and feel.

Evolence is a new dermal filler which can give you smooth, youthful looking skin by replacing your depleted collagen. Unlike many dermal filling procedures, Evolence begins working almost at once and the effects last between six months to a year. There is little to no bruising or swelling caused by this procedure and no skin testing needs to be done before beginning the procedure.

Some other benefits of Evolence over other collagen fillers are that it does not need to be refrigerated, making it easier to store. It does not contain anesthetic, unlike bovine based collagen. Evolence is porcine-based because pig skin is most like human tissue. This makes the collagen more durable, pliable and the skin softer. Instead of using chemicals, Evolence uses natural sugar to increase the durability. Evolence is also a less concentrated product than other fillers. Evolence is to be injected into the upper to mid dermis. This is where your smile lines are located, from the nose to the corners of the mouth.

Evlence is just now catching on in the U.S., but already enjoys great popularity in Europe, Israel and Canada. Many dermatologists are of the opinion that once the public becomes more aware of this product it will overtake all other collagen based dermal fillers because of its effectiveness and it long lasting results. This new breakthrough in skincare has just become available in the U.S. after gaining FDA approval in June 2008 – and now you too can enjoy the benefits of Evolence.

About the Author:
VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)



This author has published 1 articles so far.

Comments are closed